Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.

The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...

WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has ...

This week on "The Readout LOUD," STAT's biotech reporters parse what Vinay Prasad's ouster means for biotech and the FDA.

Such appeasement efforts proved insufficient to protect him from rival forces in the Republican Party, if not also in the ...

Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...

Trump and Medvedev, the deputy chairman of Russia’s Security Council, have been sparring online since Trump shortened his ...

The U.S. Food and Drug Administration should allow patients with life-threatening diseases to access promising but not fully ...

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...

Far-right provocateur Laura Loomer is crowdsourcing help to get more officials she deems disloyal to President Donald Trump ...

Loomer’s outsized influence with the president came under heightened scrutiny in April after she reportedly encouraged him to ...